oxicological research in identifying and monitor-Ing human toxicants'. He made the point that the study of industrial carcinogens emphasized the need for an appreciation of the difference between hazard and risk and suggested that, on lines similar to the Data Evaluation/Risk Assessment Sub-Group of the Clearing House on Environmental Carcinogens in the USA, groups in the UK might stUdy hazard and risk and report jointly to a decision-making body. Hazard should be assessed by a group of medical and biological experts experienced in human toxicology, while risk should 0141-{)768j79/lI0875-Q3j$OI.OOjO be the concern of animal toxicologists, hygienists, epidemiologists, analysts and industrialists. A toxicology programme based on research principles and careful analytical techniques was more likely to be protective to the workman, the consumer and the general exposed population than the simple pass-fail approach of standard protocols, attractive as they might be to the administrative mind. In short, a research-orientated approach to toxicity and hazard/risk evaluation was required.
Dr Leon Golberg (Chemical Industry Institute of Toxicology, Research Triangle Park, NC) thought that the main problem was how to react to the new discoveries in toxicology and environmental science which today come thick and fast. To cry wolf all the time could engender confusion and apathy, but hazards might be needlessly prolonged if the warnings of even preliminary findings were ignored. He called for sound data on which to base valid decisions. Claude Bernard had summed up the three stages of knowledge: an observation is made; a comparison is drawn; a judgment is rendered. The second stage should never be bypassed. In assessing the risk to human health, conclusions drawn from standard carcinogenesis bioassay procedures have serious implications for regulatory purposes, particularly in relation to occupational exposure. The mechanisms of toxic action must be studied and understood. The Report of the Royal Society's Study Group on Long-term toxic effects (London, 1978) stated that toxicology is not adequately supported as an academic discipline, and Dr Golberg warned of the danger of substituting an untried material whose potential in regard to a newly discovered toxic hazard may not be fully known. The long tradition of excessive and often ill-balanced reaction pointed the need to seek out and learn from past mistakes.
Mr Steven D Jellinek (US Environmental Protection Agency) spoke on the Toxic Substances Control Act (TSCA), emphasizing its unique Federal regulatory control of the entire chemical industry and importers. The little that is known of long-term chronic effects of chemicals has necessitated governmental action aimed at a preventive approach tothe public health and the environment, and a review of new chemicals before they are introduced. Under Section 4 of the Act industry is required to test chemicals and set standards. Mr
Jellinek told the audience that the Environmental Protection Agency (EPA) has recently produced its first standard. New standards will be published and new rules issued for testing effects, including carcinogenetic effects. With regard to the control of chemicals in commerce, action to mitigate risks would consist in labelling, control and, when necessary, banning. Under Section 5 the producer must notify the Agency of new chemicals, problems and difficulties. The US Congress has given the EPA 'a lot of discretion' and not a long list of specific mandates. Attempts must be made to resolve the conflict between the 'need to know' and the flexibility required by industry. The policy is to give the highest priority to substances posing the greatest risk, rather than acute effects. The TSCA requires the EPA to take action on those that have unreasonable risks. A balance has to be drawn between risks and advantages. Unreasonable risks cannot be determined unless it is established that there is a risk; therefore it is necessary to have a hazard assessment and to know who is exposed. The balance between risk and benefit has to be decided and will depend on proper disclosure. All information given to TSCA is confidential, except factors affecting health and safety. The American chemical industry is the most innovative and inventive in the world and these factors are more important than financial considerations. Thus confidentiality is of immense importance to the industry, but the environmentalist will say 'It is essential to know'. Therefore the EPA is faced with problems of priorities; of risk assessment in face of possibly little or no scientific data; of benefit assessment to industry and the public; and with the dilemma between establishing confidentiality and encouraging innovation, and at the same time protecting the health of the environment. In international trade the same rules must apply equally to the other countries and to the USA.
Dr Jonathan Plaut (Allied Chemical Corporation, New York) gave his own views on the implications for industry and society of the Toxic Substances Control Act. The distrust between the 'environmentalist' and the 'industrialist' breeds confusion and inefficiency by compromising communication and curtailing problem solving. He hoped the Conference would add to communication and problem solving. One of the specific areas on which the TSCA had concentrated was premanufacturing notification procedures which apply to new products and to old products with substantially new use. He recounted the steps taken by Allied Chemical in response to their increased knowledge of toxic substances and to the Act. These include an enormous effort to gather and computerize information on chemicals handled; a multi-million toxicology laboratory for in-house toxicological testing; a great increase in professional staff; a toxic risk assessment committee; and many new programmes, including a major programme of product responsibility which con-siders, among others, such issues as purchasing, research and development, manufacturing and marketing.
Alfred Khan, Adviser on Inflation to the US President, has stated that costs can intelligently be measured only in relation to the benefits they provide. Dr Plaut believed that, due to the requirements of pre-manufacturing notification regulations, the cost of testing and record-keeping will all have inflationary impact. The costs of the many protective and preventive measures required by the Federal Administration will be astronomical, and the EPA will face many difficulties in trying to achieve a number of goals in too short a timespan, shortage of manpower being a major problem. Because of the high cost to industry and to government, Dr Plaut suggests that the regulatory agencies 'must be persuaded to the necessity of costs/benefit analysis as one important step in the anti-inflation fight. While we do wish to reach the maximum attainable protection of safety and health, there is no such thing as a zero risk in life, and we must examine the costs and benefits of the regulations we propose'.
Mr Cyril 0 Burgess (Health and Safety Executive, London), speaking on 'Governmental action in the UK and the European Community' said that there was a polarization of views, with one group believing there is too much legislation and another that there is too little. Sometimes there is a call for broad-based legislation to cover every risk to health from all toxic substances, sometimes for specific legislation containing detailed requirements to cover more specific risks. Legislation should not be so tightly drafted that it inhibits innovation and improvement. The need to deploy limited resources in the most effective way must be its priority. Mr Burgess spoke primarily of the UK and EEC initiative in occupational health. The effective control of toxic substances came under four main headings: identification and assessment of risk; provision of information, instruction and training; control of exposure; and monitoring performance. 1 he aims of the Health and Safety at Work Act 1974 and of the Health and Safety Commission's discussion document 'Proposals for a Scheme for the Notification of Toxic Properties of Substances' were: to improve the chances of detection of possible occupational hazards at an early stage; and to assist the Health and Safety Executive to identify those toxic substances likely to pose the most serious risks, so that they could be more effectively controlled. Proposals have been made for a Directive by the Commission of the European Community (CEC) for a similar scheme with wider implications. The basic principles have been defined, but discussion continues on their scope and application. Basic test requirement have been largely agreed, and, as in the United States, will have a big impact in terms of cost in money and resources on manufacturers and importers. Much more needs to be known concerning the risks of toxic substances, and research sponsored by the Executive and others is proceeding on the identification and assessment of risk. In summing up, Mr Burgess said that the Health and Safety Commission's proposals for regulations for the control of lead at work contained much of the Current thinking on the control of toxic substances in the United Kingdom. Firstly, there is a requirement to assess the work to determine the degree of exposure. Those exposed may be employees, their families, employees of contractors, or members of the general public. A code of practice accompanying the regulations gives guidance on what has to be done, thus providing a baseline on which precautions appropriate to the risk can be developed. Secondly, there is a requirement to control exposure adequately, so far as is reasonably practicable by material, plant and process controls. It is only where adequate control cannot be obtained by these means that personal protective equipment is acceptable. Thirdly, the effectiveness of exposure control must be checked by monitoring lead levels in air and lead contamination, by biological monitoring and by medical surveillance. The cooperation of employees is vital and they must be fully aware of the risks and the precautions which should be observed.
Dr A N B Stott (Atomic Energy Authority, Harwell) spoke on health hazards of energy resources and their products. He classified the main energy sources under the headings of fossil, nUclear, 'renewable', geothermal and hydroelectric, and emphasized the urgent need for studies on the cost/benefits of the uses of different sources of energy in terms of national need and implications for health.
Dr Alexander Munn (Monsanto Europe SA, Brussels) said that to hope to distinguish between natural and man-made toxic agents -carcinogenic, mutagenic and teratogenic -was a sterile line of approach. What was important was to identify hazards that harm man and to bring them under control, not necessarily by regulatory measures.
Mr John P McCullough (Mobil Oil Corporation, New York) stated that there is no longer any debate about the responsibility of industry and commerce to incur the cost of cleaning up the environment, maintaining a safe working place and selling safe products. But by the law of diminishing returns, now that 'controls are becoming more stringent, benefits are becoming more difficult to achieve and costs are mounting... Because time is money regulatory delays can be costly'. He believed that the Occupational Safety and Health Administration (OSHA) should consider its priorities, though he commended the fact that 'nearly a thousand nit-picking regulations have recently been repealed'. He urged the regulators to work with the regulated so that all costs and benefits can be fully assessed.
Dr Robert Murray (President of the RSM Section of Occupational Medicine) attempted a forecast of future hazards to human health, based upon elementary facts and a few hunches. He did not believe that human nature would change: in the future there might be a slightly thicker veneer of civilization, but the more people expect the more they will want. Doctors will be dealing with the effects, but will be powerless to deal with the social causes of ill health.
The last speaker was Dr Eula Bingham, nominated by President Carter and appointed Assistant Secretary of Labor, Occupational Safety and Health Administration, Washington. She has responsibility for the safety and health of 70-90 million workers in the USA, and spoke on 'Awareness in industry and the general public'. Dr Bingham said the level of public awareness in the USA is quite different from that in Britain. The development of American economy was based on small industries and transportation. The dangers were easy to identify. The first attempt at regulation had been the control of boilers in steam-boats; because the dangers of explosion resulting in passengers being thrown into the river were readily recognized, there was no opposition and no call for cost benefit. Attitudes to obvious hazards are easily defined, but the concept of epidemiological studies, dose-response relationships and latency are all difficult for Americans to comprehend. She gave examples of public outcry over disasters in grain elevators and tower collapses, but said that asbestos and sweat-shop factories caused no outcry. Most American workers die quietly and ignorantly of diagnoses which may be deceptive and may be secondary to the results of occupational exposure. She discussed a number of environmental and workplace problems, and stated that it was difficult to obtain compensation for occupational diseases as so often they are not recognized. Most businesses (90%) employ less than 25 workers. It is very difficult to instill health and safety. OSHA aims to stimulate new methods of informing and educating workers and employers on the presence of hazards in the workplace.
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